CD44 and cancer: Furthermore, among the seven markers (CD13, CD24, CD44, CD90, CD133, EPCAM and ALDH1A1)27 of cancer stem cells (CSCs) in HCC, five were downregulated after cFAM210A overexpression (Fig. 5g).